Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Personalis files to sell 11.53M shares of common stock for holders  16:31
07/02/20
07/02
16:31
07/02/20
16:31
PSNL

Personalis

$14.24 /

+0.51 (+3.71%)

 
ShowHide Related Items >><<
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

Syndicate
Personalis files $250M mixed securities shelf  16:30
07/02/20
07/02
16:30
07/02/20
16:30
PSNL

Personalis

$14.24 /

+0.51 (+3.71%)

 
ShowHide Related Items >><<
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$14.24 /

+0.51 (+3.71%)

PSNL Personalis
$14.24 /

+0.51 (+3.71%)

Hot Stocks
Personalis completes 75,000 whole human genome sequenced under VA MVP contract » 08:12
06/24/20
06/24
08:12
06/24/20
08:12
PSNL

Personalis

$13.80 /

+0.32 (+2.37%)

Personalis announced its…

Personalis announced its completion of 75,000 whole human genome sequenced under its contract with the U.S. Department of Veterans Affairs Million Veteran Program, or VA MVP. All genomes were sequenced in the company's laboratory in Menlo Park, California. With over 825,000 veterans enrolled to date and a recently increased target of two million enrollees, the VA MVP is the largest population sequencing program in the U.S. Personalis was first contracted by the VA MVP to provide DNA sequencing and data analysis services in 2012.

ShowHide Related Items >><<
PSNL Personalis
$13.80 /

+0.32 (+2.37%)

PSNL Personalis
$13.80 /

+0.32 (+2.37%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$13.80 /

+0.32 (+2.37%)

PSNL Personalis
$13.80 /

+0.32 (+2.37%)

Hot Stocks
Catalyst Biosciences appoints Clinton Musil as CFOPersonalis » 08:04
06/15/20
06/15
08:04
06/15/20
08:04
CBIO

Catalyst Biosciences

$7.44 /

+0.31 (+4.35%)

, PSNL

Personalis

$11.68 /

-0.28 (-2.34%)

Catalyst Biosciences…

Catalyst Biosciences (CBIO) announced the appointment of Clinton Musil as its new CFO, effective July 1, 2020. Clinton Musil previously held the position of chief business officer at Personalis (PSNL).

ShowHide Related Items >><<
PSNL Personalis
$11.68 /

-0.28 (-2.34%)

CBIO Catalyst Biosciences
$7.44 /

+0.31 (+4.35%)

CBIO Catalyst Biosciences
$7.44 /

+0.31 (+4.35%)

05/21/20 Raymond James
Catalyst Biosciences initiated with an Outperform at Raymond James
PSNL Personalis
$11.68 /

-0.28 (-2.34%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$11.68 /

-0.28 (-2.34%)

CBIO Catalyst Biosciences
$7.44 /

+0.31 (+4.35%)

PSNL Personalis
$11.68 /

-0.28 (-2.34%)

On The Fly
Fly Intel: After-Hours Movers » 19:02
06/10/20
06/10
19:02
06/10/20
19:02
TLRD

Tailored Brands

$1.24 /

-0.11 (-8.15%)

, JACK

Jack in the Box

$71.09 /

-0.38 (-0.53%)

, GRUB

GrubHub

$59.85 /

+1.93 (+3.33%)

, PSNL

Personalis

$13.05 /

-0.09 (-0.68%)

, SRT

StarTek

$4.92 /

-0.16 (-3.15%)

, OXM

Oxford Industries

$51.71 /

-3.32 (-6.03%)

, MBIO

Mustang Bio

$3.74 /

-0.5 (-11.79%)

, CTLT

Catalent

$74.61 /

-0.29 (-0.39%)

, CIM

Chimera

$10.61 /

-0.54 (-4.84%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

SRT StarTek
$4.92 /

-0.16 (-3.15%)

PSNL Personalis
$13.05 /

-0.09 (-0.68%)

OXM Oxford Industries
$51.71 /

-3.32 (-6.03%)

MBIO Mustang Bio
$3.74 /

-0.5 (-11.79%)

JACK Jack in the Box
$71.09 /

-0.38 (-0.53%)

GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

CTLT Catalent
$74.61 /

-0.29 (-0.39%)

CIM Chimera
$10.61 /

-0.54 (-4.84%)

TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

03/19/20 Deutsche Bank
Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
06/13/19 B. Riley FBR
Tailored Brands price target lowered to $7 from $10 at B. Riley FBR
JACK Jack in the Box
$71.09 /

-0.38 (-0.53%)

05/27/20
Fly Intel: Top five analyst upgrades
05/26/20 Goldman Sachs
Jack in the Box upgraded to Neutral from Sell at Goldman Sachs
05/26/20 Goldman Sachs
Jack in the Box upgraded to Neutral from Sell at Goldman Sachs
05/15/20 Truist
Jack in the Box price target raised to $86 from $79 at SunTrust
GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

06/10/20 BTIG
GrubHub initiated with a Neutral at BTIG
06/10/20 Needham
Logic of GrubHub takeover by Just Eat 'looks questionable,' says Needham
06/09/20 Jefferies
GrubHub price target raised to $62 from $50 at Jefferies
06/08/20 Jefferies
Uber can likely bid higher than EU rivals for GrubHub, says Jefferies
PSNL Personalis
$13.05 /

-0.09 (-0.68%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
SRT StarTek
$4.92 /

-0.16 (-3.15%)

04/08/20 B. Riley FBR
StarTek price target lowered to $6 from $10.50 at B. Riley FBR
03/13/20 Lake Street
StarTek valuation compelling after strong Q4, says Lake Street
01/09/20
Fly Intel: Top five analyst initiations
01/09/20 B. Riley FBR
B. Riley FBR starts StarTek with Buy rating, $10.50 price target
OXM Oxford Industries
$51.71 /

-3.32 (-6.03%)

06/08/20 Needham
Oxford Industries price target raised to $62 from $50 at Needham
03/27/20 KeyBanc
Oxford Industries price target lowered to $54 from $86 at KeyBanc
01/29/20 Needham
Oxford Industries upgraded to Buy from Hold at Needham
01/29/20 Needham
Oxford Industries upgraded to Buy from Hold at Needham
MBIO Mustang Bio
$3.74 /

-0.5 (-11.79%)

02/18/20 H.C. Wainwright
'Not a bad start' for Mustang Bio's MB-106 news, says H.C. Wainwright
01/09/20 Cantor Fitzgerald
Mustang Bio named top pick for 2020 at Cantor Fitzgerald
11/20/19 Cantor Fitzgerald
Mustang Bio assumed with an Overweight at Cantor Fitzgerald
08/13/19 H.C. Wainwright
Mustang Bio initiated with a Buy at H.C. Wainwright
CTLT Catalent
$74.61 /

-0.29 (-0.39%)

05/06/20 Baird
Catalent price target raised to $74 from $63 at Baird
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/20/20 RBC Capital
Catalent initiated with an Outperform at RBC Capital
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
CIM Chimera
$10.61 /

-0.54 (-4.84%)

05/18/20 RBC Capital
Chimera price target lowered to $11 from $23 at RBC Capital
10/02/19 RBC Capital
RBC Capital initiates select mortgage REITs with 'constructive' outlook
10/02/19 RBC Capital
Chimera initiated with an Outperform at RBC Capital
10/02/19 RBC Capital
Chimera initiated with an Outperform at RBC Capital
TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

SRT StarTek
$4.92 /

-0.16 (-3.15%)

PSNL Personalis
$13.05 /

-0.09 (-0.68%)

OXM Oxford Industries
$51.71 /

-3.32 (-6.03%)

JACK Jack in the Box
$71.09 /

-0.38 (-0.53%)

GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

CTLT Catalent
$74.61 /

-0.29 (-0.39%)

CIM Chimera
$10.61 /

-0.54 (-4.84%)

  • 11
    Jun
  • 11
    Jun
TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

CTLT Catalent
$74.61 /

-0.29 (-0.39%)

TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

JACK Jack in the Box
$71.09 /

-0.38 (-0.53%)

GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

CIM Chimera
$10.61 /

-0.54 (-4.84%)

TLRD Tailored Brands
$1.24 /

-0.11 (-8.15%)

OXM Oxford Industries
$51.71 /

-3.32 (-6.03%)

GRUB GrubHub
$59.85 /

+1.93 (+3.33%)

CIM Chimera
$10.61 /

-0.54 (-4.84%)

Hot Stocks
Personalis to partner with Berry Genomics for China expansion » 16:06
06/10/20
06/10
16:06
06/10/20
16:06
PSNL

Personalis

$13.18 /

+0.035 (+0.27%)

Personalis announced the…

Personalis announced the partnership with Berry Genomics, headquartered in the People's Republic of China. Personalis will be expanding business operations in the People's Republic of China in 2020, and plans to form a wholly-owned subsidiary in Shanghai. The expansion will include building out a laboratory operation for local customers to use its ImmunoID NeXT PlatformTM, a commercial team to support local customers, and general and administrative functions. Under terms of the agreement, Berry Genomics will provide Personalis certain services and local support.

ShowHide Related Items >><<
PSNL Personalis
$13.18 /

+0.035 (+0.27%)

PSNL Personalis
$13.18 /

+0.035 (+0.27%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$13.18 /

+0.035 (+0.27%)

Conference/Events
Personalis management to meet virtually with SunTrust » 04:55
06/09/20
06/09
04:55
06/09/20
04:55
PSNL

Personalis

$13.45 /

+0.13 (+0.98%)

Virtual Meeting to be…

Virtual Meeting to be held on June 9 hosted by SunTrust.

ShowHide Related Items >><<
PSNL Personalis
$13.45 /

+0.13 (+0.98%)

PSNL Personalis
$13.45 /

+0.13 (+0.98%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$13.45 /

+0.13 (+0.98%)

Conference/Events
Personalis management to meet virtually with SunTrust » 07:40
06/08/20
06/08
07:40
06/08/20
07:40
PSNL

Personalis

$13.32 /

-0.78 (-5.53%)

Virtual Meeting to be…

Virtual Meeting to be held on June 9 hosted by SunTrust.

ShowHide Related Items >><<
PSNL Personalis
$13.32 /

-0.78 (-5.53%)

PSNL Personalis
$13.32 /

-0.78 (-5.53%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
PSNL Personalis
$13.32 /

-0.78 (-5.53%)

Hot Stocks
Personalis, Sarepta collaborate on precision genetic therapeutics » 08:14
06/02/20
06/02
08:14
06/02/20
08:14
PSNL

Personalis

$13.21 /

+1.37 (+11.57%)

, SRPT

Sarepta

$149.73 /

-2.57 (-1.69%)

Personalis (PSNL)…

Personalis (PSNL) announced a collaboration with Sarepta. As part of this research collaboration, Sarepta (SRPT) will be working with the Personalis team to characterize immune response to precision genetic therapeutics, utilizing Personalis' advanced proprietary analytics.

ShowHide Related Items >><<
SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

PSNL Personalis
$13.21 /

+1.37 (+11.57%)

PSNL Personalis
$13.21 /

+1.37 (+11.57%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen
SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

05/28/20 Piper Sandler
Sarepta to likely report positive SRP-9003 data next month, says Piper Sandler
05/15/20 Goldman Sachs
After Pfizer data, Goldman says Sarepta remains 'leader' in DMD gene therapy
05/15/20 William Blair
Sarepta remains the leader after Pfizer DMD data, says William Blair
05/15/20 William Blair
Sarepta remains the leader after Pfizer DMD data, says William Blair
SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

PSNL Personalis
$13.21 /

+1.37 (+11.57%)

SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

SRPT Sarepta
$149.73 /

-2.57 (-1.69%)

Earnings
Personalis reports Q1 EPS (29c), consensus (25c) » 16:16
05/07/20
05/07
16:16
05/07/20
16:16
PSNL

Personalis

$10.31 /

-0.21 (-2.00%)

Reports Q1 revenue…

Reports Q1 revenue $19.2M, consensus $17.2M. "I'm proud to say that we were able to report record revenues once again this quarter, in spite of the initial impact from the COVID-19 pandemic, and continued to see strong ordering levels from both our existing and new customers," said John West, Chief Executive Officer. "Also, while our laboratory operations have been scaled down due to the COVID-19 shelter-in-place orders, and will be at least through May, we feel well-positioned to work through our VA MVP samples and also service our biopharma customers when they are able to send us their samples." Due to uncertainty surrounding the COVID-19 pandemic, Personalis will not provide an outlook for fiscal 2020 at this time, and will plan to give an update during its second quarter earnings announcement and press release, to the extent practicable, based on available information at that time.

ShowHide Related Items >><<
PSNL Personalis
$10.31 /

-0.21 (-2.00%)

11/14/19 Oppenheimer
Personalis price target lowered to $26 from $29 at Oppenheimer
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
Personalis upgraded to Buy from Neutral at BofA/Merrill
07/15/19 Cowen
Personalis initiated with an Outperform at Cowen

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.